A FOUR DAY CORTICOTROPHIN-SUPPRESSION TEST
- 1 January 1965
- journal article
- research article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 48 (1) , 147-162
- https://doi.org/10.1530/acta.0.0480147
Abstract
A 4 day ACTH-suppression test was performed in 58 patients showing symptoms often associated with hypercorticism and in 25 cases of Cushing''s syndrome. The non Cushing patients suffered from obesity, hypertension, plethora, diabetes and mental disturbances in various combinations and/or conditions related to hypertrichosis and menstrual disorders. Some of them also showed an increased basal excretion of 17-ketosteroids. Triamcinolone, in doses of 4 mg and 8 mg every 6 hours or 2 mg of dexamethasone every 6 hours, induced a good suppression of adrenocortlcal function in the non Cushing patients. This was demonstrated by chromatographic analysis of 24 different 24-hour urine samples collected on the third or fourth day of the test. In these cases - selected at random from the 58 non Cushing patients - the mean excretion of tetrahydroderivatlves of cortisone and cortisol was <0.3 mg/day (range 0.0-1.2 mg/day). Only traces of dehydroepiandro-sterone and 11-oxy-17-ketosterolds were found. In all cases, 17-ketogenic steroids, Porter-Silber chromogens and 17-ketosteroids were determined by routine methods and the results are discussed with regard to the presence of non specific chromogens. There was no difference in the urinary excretion of steroids during the administration of 16 mg and 32 mg respectively of triamcinolone and of 8 mg of dexamethasone daily. In 9 of 11 cases of non-tumorous Cushing''s syndrome, triamcinolone in a dose of 4 mg every 6 hours did not suppress the urinary excretion of 17-ketogenic steroids, Porter-Silber chromogens or 17-ketosteroids normally. In 2 cases, however, there was a normal suppression according to the criteria chosen. In 4 cases of non-tumorous Cushing''s syndrome, suppression could not be demonstrated during the administration of triamcinolone in a dose of 16 mg every 6 hours for 4 days. Because of the varying degrees of suppression found in Cushing''s syndrome, the diagnostic conclusions drawn from the ACTH-suppression test should be made with caution. Marked variation in the basal excretion of steroids adds to the difficulties as do the limitations of the test imposed by unspecificity of the methods used in evaluation the adreno-cortical function.Keywords
This publication has 8 references indexed in Scilit:
- ROUTINE DETERMINATIONS OF 17-KETOSTEROIDS AND PORTER-SILBER CHROMOGENS COMPARED WITH THE CHROMATOGRAPHIC MEASUREMENT OF GROUPED AND INDIVIDUAL STEROIDSActa Endocrinologica, 1964
- CUSHING'S SYNDROME WITH ATYPICAL BIOCHEMICAL RESULTSActa Endocrinologica, 1964
- Failure of Dexamethasone Suppression Test To Indicate Bilateral Adrenocortical Hyperplasia in Cushing's SyndromeJournal of Clinical Endocrinology & Metabolism, 1963
- A COMPARISON OF CHARACTERISTICS OF INCREASED ADRENOCORTICAL FUNCTION IN OBESITY AND IN CUSHINGS SYNDROME1963
- EXCRETION DES STEROIDES CHEZ DES FEMMES PRESENTANT UN VIRILISME PILAIRE ASSOCIE A DES TROUBLES DU CYCLE MENSTRUELActa Endocrinologica, 1961
- TESTS OF PITUITARY-ADRENAL SUPPRESSIBILITY IN THE DIAGNOSIS OF CUSHING'S SYNDROME*Journal of Clinical Endocrinology & Metabolism, 1960
- Indirect analysis of corticosteroids. 1. The determination of 17-hydroxycorticosteroidsBiochemical Journal, 1955
- ASSESSMENT OF ADRENOCORTICAL ACTIVITY BY ASSAY OF 17-KETOGENIC STEROIDS IN URINEThe Lancet, 1953